BioSpace News Archive

Company also exhibiting cloud-based transportation coordination platform at RISE Medicare Advantage Summit and AMGA Annual Conference

BioIVT’s acquisition of Clinical Trial Laboratory Services (CTLS) and its London donor center is enabling this rapid turnaround time for high quality blood-derived immune cells for cell and gene therapy research

Inovio Pharmaceuticals, Inc. announced an accelerated timeline for developing its DNA vaccine INO-4800 to address COVID-19, the respiratory infection the World Health Organization has designated a Public Health Emergency of International Concern of the highest level.

GALE|QKIT allows municipalities and governments to safely monitor patients’ health at home using smart diagnostic devices, maximizing the period during which individuals being evaluated for possible infection can remain at home

Updated overall survival (OS) data for Part A demonstrated 83% 12-month OS rate among vaccine responders vs. 33% for non-responders

Agilent Technologies Inc. introduced three new microarrays to meet the needs of cytogenetic laboratories conducting both prenatal and postnatal research.

Eko honored for achievements in AI-powered solutions to improve cardiac care

EPA’s ToxCast™ evaluation of the developmental toxicity risk of 1,065 compounds using Stemina’s devTOX quickPredict test (devTOXqP) published in Toxicological Sciences

NEO is pleased to announce it has granted final approval to Mind Medicine Inc., the leading neuro-pharmaceutical company for psychedelic-inspired medicines, to make its global public markets debut.

The Ellipsys® Vascular Access System enables patients with kidney failure to start dialysis treatment sooner with fewer procedures, complications and interventions compared to surgery, according to several leading physicians who spoke at the recent meeting of the American Society of Diagnostic and Interventional Nephrology.